Letter: Therapeutic Drug Monitoring and Inflammatory Bowel Disease-A Call for an Urgent Standardization of the Results

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Gastroenterology
HepatologyGastroenterology
2017English

Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Recommended Drug Therapies for Inflammatory Bowel Disease

Prescriber
Pharmacology
2018English

Letter: Inflammatory Bowel Disease and Risk of Myocardial Infarction

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2020English

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease

Clinical Endoscopy
MedicineNuclear MedicineRadiologyImagingGastroenterology
2017English

Novel Therapeutic Targets in Inflammatory Bowel Disease

Prescriber
Pharmacology
2019English

Palliative Care for Drug-Resistant Tuberculosis: An Urgent Call to Action

South African Medical Journal
Medicine
2018English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Physiological Basis for Novel Drug Therapies Used to Treat the Inflammatory Bowel Diseases I. Immunology and Therapeutic Potential of Antiadhesion Molecule Therapy in Inflammatory Bowel Disease

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy